The Indian Council of Medical Research (ICMR) today announced the results of the 3rd National Serological Survey, which revealed that 21.5% of India’s population, or about one-fifth, has been infected with New Coronary Pneumonia, equating to nearly 280 million people who have been infected.
The Ministry of health and Family Welfare and the Indian Council of Medical Research (ICMR) today announced the results of the 3rd national serological survey conducted from December 17 last year to January 8 this year, which found that 21.5% of India’s population had been infected with coronavirus disease 2019 (COVID- 19, Wuhan pneumonia, CCPV).
A total of 28,589 serum samples were randomly surveyed across India this Time, including a group of 7,171 health care workers.
This national serosurvey showed that urban slums had the highest seroprevalence, with approximately 31.7% having been infected with Wuhan pneumonia. High population density, high mobility and failure to maintain safe distances and poor hygiene practices such as hand washing were the main causes of Wuhan pneumonia infection among urban slum dwellers.
The 2nd National Serological Survey of India had found that the proportion of urban slum dwellers infected with Wuhan pneumonia was twice that of non-slum area dwellers and four times that of rural areas.
According to Balram Bhargava, director general of ICMR, the sero-survey results show that a large number of people are still vulnerable to Wuhan pneumonia and need to be vaccinated, according to the Indian Express and other media reports.
VK Paul, a member of the official Indian think tank NITI Aayog, said that health care workers who received the first dose of the vaccine in the first phase of the Wuhan pneumonia vaccination program, which began on January 16, will receive the second dose from February 13.
According to the Ministry of Health and Family Welfare, about 30% of health care workers in 11 provinces and UTs, including Tamil Nadu, Assam and Jammu and Kashmir, have been vaccinated.
The 300 million people who received the first phase of the free Wuhan pneumonia vaccine in India could not choose which vaccine to administer, and the Indian vaccine Covaxin was approved by the government for emergency use because it had not yet passed phase III clinical trials, raising safety concerns and causing many Indian health care workers to refuse to administer the vaccine for fear of serious side effects after receiving it.
Rajesh Bhushan, undersecretary of the Indian Ministry of Health and Family Welfare, said that India has an Adverse Event Following Immunization (AEFI) surveillance system to further enhance vaccination.
Bhushan stressed that so far, for every 100,000 people vaccinated with Wuhan pneumonia vaccine, only 8,563 cases of post-vaccination adverse reactions have occurred.
According to the Ministry of Health and Welfare, 4.5 million people have been vaccinated within 19 days of the launch of the Wuhan pneumonia vaccination, making India the fastest country in the world to reach 4 million people vaccinated in just 18 days.
Bhushan also pointed out that the Epidemic of Wuhan pneumonia in India is improving day by day, with a positive rate of 1.82% of samples tested daily, and 155,000 active cases of Wuhan pneumonia requiring treatment, accounting for only 1.44% of the total number of infections, with 10,480,455 people having recovered.
However, as of today, the cumulative number of cases of Wuhan pneumonia in India stands at 10.79 million, still the 2nd highest in the world, with a total of 154,742 deaths, also among the top 4 in the world.
Recent Comments